Valérie Zombré
Dados Biográficos
| ID | 7794351 |
|---|---|
| NOME | Valérie Zombré |
| PRENOMES | Valérie |
| SOBRENOME | Zombré |
| ASSINATURA | ZOMBRÉ V |
| AFILIAÇÕES | Ministère de la Santé |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 4 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 4 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2025 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Integration of azithromycin mass administration to 1–11-month-old children into an existing health platform to reduce child mortality
BACKGROUND: Azithromycin mass drug administration (MDA) to ages 1-59 months can reduce childhood mortality; however, more evidence is needed to support targeting a narrower age range of 1-11 months. This trial assesses the efficacy of azithromycin MDA to 1-11-month-old children in reducing mortality in a real-world setting with integration of vitamin A delivery within the established Child Health Days platform in Burkina Faso. METHODS: Mortalite …
Household costs of care in children under five attending primary care in Burkina Faso, Guinea, Mali and Niger
INTRODUCTION: Out-of-pocket payments limit access to care in Africa. The Amélioration de l'Identification des détresses Respiratoires de l'Enfant/Improving Identification of Respiratory Distress in Children (AIRE) project evaluated the implementation of pulse oximetry within Integrated Management of Childhood Illness (IMCI) guidelines at primary health centres (PHCs) in Burkina Faso and Niger (with total exemption policies) and in Mali and Guinea…
Challenges and needs before implementing routine pulse oximetry within primary care for sick children in West Africa
BACKGROUND: The Integrated Management of Childhood Illness (IMCI) guidelines are implemented within primary health centres (PHCs) in resource-limited settings. These symptom-based algorithms under-diagnose severe hypoxemia, which contributes to the under-five'mortality in sub-Saharan Africa. To improve the diagnosis and management of severe hypoxaemia, the Améliorer l'Identification des détresses Respiratoires chez l'Enfant (AIRE) project impleme…
Care pathways for critically ill children aged 0–5 years arriving at district hospitals in Burkina Faso, Guinea, Mali, and Niger (2022)
The recommended pathway is largely adhered to, yet parallel pathways require attention, notably in Guinea and Mali. A better understanding of healthcare-seeking behaviours can help remove barriers to care, improving the likelihood that a sick child will receive optimal care
Sem obras proeminentes nesta página.
Household costs of care in children under five attending primary care in Burkina Faso, Guinea, Mali and Niger
INTRODUCTION: Out-of-pocket payments limit access to care in Africa. The Amélioration de l'Identification des détresses Respiratoires de l'Enfant/Improving Identification of Respiratory Distress in Children (AIRE) project evaluated the implementation of pulse oximetry within Integrated Management of Childhood Illness (IMCI) guidelines at primary health centres (PHCs) in Burkina Faso and Niger (with total exemption policies) and in Mali and Guinea…
Challenges and needs before implementing routine pulse oximetry within primary care for sick children in West Africa
BACKGROUND: The Integrated Management of Childhood Illness (IMCI) guidelines are implemented within primary health centres (PHCs) in resource-limited settings. These symptom-based algorithms under-diagnose severe hypoxemia, which contributes to the under-five'mortality in sub-Saharan Africa. To improve the diagnosis and management of severe hypoxaemia, the Améliorer l'Identification des détresses Respiratoires chez l'Enfant (AIRE) project impleme…
Care pathways for critically ill children aged 0–5 years arriving at district hospitals in Burkina Faso, Guinea, Mali, and Niger (2022)
The recommended pathway is largely adhered to, yet parallel pathways require attention, notably in Guinea and Mali. A better understanding of healthcare-seeking behaviours can help remove barriers to care, improving the likelihood that a sick child will receive optimal care
Integration of azithromycin mass administration to 1–11-month-old children into an existing health platform to reduce child mortality
BACKGROUND: Azithromycin mass drug administration (MDA) to ages 1-59 months can reduce childhood mortality; however, more evidence is needed to support targeting a narrower age range of 1-11 months. This trial assesses the efficacy of azithromycin MDA to 1-11-month-old children in reducing mortality in a real-world setting with integration of vitamin A delivery within the established Child Health Days platform in Burkina Faso. METHODS: Mortalite …
Public health (3 obras) · Child health (2 obras) · Global Maternal and Child Health (2 obras) · MEDLINE (2 obras) · Primary care (2 obras) · Primary health care (2 obras) · Sick child (2 obras) · Azithromycin (1 obras) · Biostatistics (1 obras) · Child Nutrition and Water Access (1 obras)